இந்தியன் மருந்து உற்பத்தியாளர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Text Size: A+ New Delhi: Domestic pressure, coupled with a severe shortage, has brought India’s Covid-19 vaccine diplomacy Vaccine Maitri to a screeching halt, but neighbouring countries are now urging New Delhi to at least free up their commercial vaccine shipments in order to prevent the outbreak of second and third waves of Covid-19 there, ThePrint has learnt. Under the Vaccine Maitri initiative, while India had gifted the Serum Institute of India (SII)-manufactured Covishield vaccines to its friends in the neighbourhood, countries such as  Nepal, Bangladesh and Sri Lanka have also bought millions of doses from the vaccine maker directly.

Sri lankaNew delhiCity ofUnited kingdomSri lankanTarun prashanthDhiraj singh bloombergAshok madanBeximco pharmaSerum institute of india ltdOxford astrazeneca plcSerum institute of indiaIndian drug manufacturer associationSerum instituteIndia ltdDhiraj singh